KR20090129981A - 항혈전 활성을 갖는 이미노이미다조피리딘 유도체 - Google Patents
항혈전 활성을 갖는 이미노이미다조피리딘 유도체 Download PDFInfo
- Publication number
- KR20090129981A KR20090129981A KR1020097002137A KR20097002137A KR20090129981A KR 20090129981 A KR20090129981 A KR 20090129981A KR 1020097002137 A KR1020097002137 A KR 1020097002137A KR 20097002137 A KR20097002137 A KR 20097002137A KR 20090129981 A KR20090129981 A KR 20090129981A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- alkylene
- formula
- het
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 Cc1c(*)c2c(*)nc(N)[n]2c(*)c1C Chemical compound Cc1c(*)c2c(*)nc(N)[n]2c(*)c1C 0.000 description 4
- BSVMUEBEMPWSEB-UHFFFAOYSA-N CC(C)(C)c(cc(cc1C(C)(C)C)C(CNC(c2ccccc2)c2ccccn2)=O)c1O Chemical compound CC(C)(C)c(cc(cc1C(C)(C)C)C(CNC(c2ccccc2)c2ccccn2)=O)c1O BSVMUEBEMPWSEB-UHFFFAOYSA-N 0.000 description 1
- FURFAZDJPIDHDQ-UHFFFAOYSA-N CC(C)(C)c1cc(C(CN(C=C(C=C2)N3C=C2C(OC)=O)C3=N)=O)cc(N2CCOCC2)c1OC Chemical compound CC(C)(C)c1cc(C(CN(C=C(C=C2)N3C=C2C(OC)=O)C3=N)=O)cc(N2CCOCC2)c1OC FURFAZDJPIDHDQ-UHFFFAOYSA-N 0.000 description 1
- BJEZKCFCIMRPHH-UHFFFAOYSA-N CC(C)(C)c1cc(C(CN(C=C2N3C=CC=C2)C3=N)=O)cc(N2CCOCC2)c1OC Chemical compound CC(C)(C)c1cc(C(CN(C=C2N3C=CC=C2)C3=N)=O)cc(N2CCOCC2)c1OC BJEZKCFCIMRPHH-UHFFFAOYSA-N 0.000 description 1
- MLSSKZAADYBDSX-UHFFFAOYSA-N CCOC(C(C=C(N12)OC)=CC1=CNC2=N)=O Chemical compound CCOC(C(C=C(N12)OC)=CC1=CNC2=N)=O MLSSKZAADYBDSX-UHFFFAOYSA-N 0.000 description 1
- RISNQWXACBKLOI-UHFFFAOYSA-N CCOC(c1cc(CNC(NC(OCC2c3ccccc3-c3ccccc23)=O)=S)nc(OC)c1)=O Chemical compound CCOC(c1cc(CNC(NC(OCC2c3ccccc3-c3ccccc23)=O)=S)nc(OC)c1)=O RISNQWXACBKLOI-UHFFFAOYSA-N 0.000 description 1
- WBTQRUCZQMHVAM-UHFFFAOYSA-N CCOc1cc(CNC(NC(OCC2c3ccccc3-c3c2cccc3)=O)=S)ncc1C(NC)=O Chemical compound CCOc1cc(CNC(NC(OCC2c3ccccc3-c3c2cccc3)=O)=S)ncc1C(NC)=O WBTQRUCZQMHVAM-UHFFFAOYSA-N 0.000 description 1
- GYVVVZPFTRODCK-UHFFFAOYSA-N CNc1cc(C(CBr)=O)cc(S(F)(F)(F)(F)F)c1 Chemical compound CNc1cc(C(CBr)=O)cc(S(F)(F)(F)(F)F)c1 GYVVVZPFTRODCK-UHFFFAOYSA-N 0.000 description 1
- QNZJNHBJBVFLEW-UHFFFAOYSA-N COc(c(C(F)(F)F)cc(C(CBr)=O)c1)c1N1CCOCC1 Chemical compound COc(c(C(F)(F)F)cc(C(CBr)=O)c1)c1N1CCOCC1 QNZJNHBJBVFLEW-UHFFFAOYSA-N 0.000 description 1
- NUMVGXMLSFDRRX-UHFFFAOYSA-N Nc1cc(S(F)(F)(F)(F)F)cc(C(O)=O)c1 Chemical compound Nc1cc(S(F)(F)(F)(F)F)cc(C(O)=O)c1 NUMVGXMLSFDRRX-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006036023.0 | 2006-08-02 | ||
| DE102006036023A DE102006036023A1 (de) | 2006-08-02 | 2006-08-02 | Imino-imidazo-pyridinderivate mit antithrombotischer Aktivität |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20090129981A true KR20090129981A (ko) | 2009-12-17 |
Family
ID=38884850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020097002137A Abandoned KR20090129981A (ko) | 2006-08-02 | 2007-07-18 | 항혈전 활성을 갖는 이미노이미다조피리딘 유도체 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7863269B2 (https=) |
| EP (1) | EP2054412B1 (https=) |
| JP (1) | JP5149897B2 (https=) |
| KR (1) | KR20090129981A (https=) |
| CN (1) | CN101495478B (https=) |
| AR (1) | AR062158A1 (https=) |
| AT (1) | ATE450537T1 (https=) |
| AU (1) | AU2007280780B2 (https=) |
| BR (1) | BRPI0714599A2 (https=) |
| CA (1) | CA2663332C (https=) |
| CL (1) | CL2007002240A1 (https=) |
| DE (2) | DE102006036023A1 (https=) |
| DK (1) | DK2054412T3 (https=) |
| DO (1) | DOP2007000120A (https=) |
| ES (1) | ES2336044T3 (https=) |
| IL (1) | IL196789A (https=) |
| MX (1) | MX2009000408A (https=) |
| MY (1) | MY148611A (https=) |
| NO (1) | NO20090741L (https=) |
| PE (1) | PE20080687A1 (https=) |
| PT (1) | PT2054412E (https=) |
| TW (1) | TWI400240B (https=) |
| WO (1) | WO2008014888A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS52264B (sr) * | 2008-02-05 | 2012-10-31 | Sanofi | Triazolopiridazini kao inhibitori par1, njihovo dobijanje i upotreba kao lekova |
| US20160040247A1 (en) | 2013-03-15 | 2016-02-11 | Fundació Institut De Recerca Biomèdica (Irb Barcelona) | Method for the diagnosis, prognosis, and tratment of cancer metastasis |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5124517B1 (https=) * | 1971-03-15 | 1976-07-24 | ||
| DE2221796A1 (de) | 1972-05-04 | 1973-11-15 | Kraemer Kg Wilhelm | Batteriebehaelter fuer stabbatterien |
| JPS60161986A (ja) * | 1983-12-24 | 1985-08-23 | Nippon Soda Co Ltd | イミダゾ（１，５−ａ）ピリジン−３−オン誘導体及びその製造方法 |
| US6063847A (en) * | 1997-11-25 | 2000-05-16 | Schering Corporation | Thrombin receptor antagonists |
| US7488742B2 (en) * | 2000-06-15 | 2009-02-10 | Schering Corporation | Thrombin receptor antagonists |
| EP1394152A4 (en) * | 2001-04-19 | 2005-02-02 | Eisai Co Ltd | 2-IMINOIMIDAZOLE DERIVATIVES (1) |
| BRPI0309309B8 (pt) | 2002-04-16 | 2021-05-25 | Merck Sharp & Dohme | antagonistas de receptor de trombina tricíclicos |
| CN100439336C (zh) | 2003-02-19 | 2008-12-03 | 卫材R&D管理有限公司 | 制备环状苯甲脒衍生物的方法 |
| DE10353205A1 (de) | 2003-11-13 | 2005-06-16 | Aventis Pharma Deutschland Gmbh | Ortho-substituierte Pentafluorsulfuranyl-Benzole, Verfahren zu ihrer Herstellung sowie ihre Verwendung als wertvolle Synthese-Zwischenstufen |
| US7317124B2 (en) * | 2003-11-13 | 2008-01-08 | Sanofi-Aventis Deutschland Gmbh | Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates |
-
2006
- 2006-08-02 DE DE102006036023A patent/DE102006036023A1/de not_active Withdrawn
-
2007
- 2007-07-18 WO PCT/EP2007/006360 patent/WO2008014888A2/de not_active Ceased
- 2007-07-18 ES ES07765222T patent/ES2336044T3/es active Active
- 2007-07-18 EP EP07765222A patent/EP2054412B1/de not_active Not-in-force
- 2007-07-18 MY MYPI20090170A patent/MY148611A/en unknown
- 2007-07-18 DE DE502007002219T patent/DE502007002219D1/de active Active
- 2007-07-18 CA CA2663332A patent/CA2663332C/en not_active Expired - Fee Related
- 2007-07-18 MX MX2009000408A patent/MX2009000408A/es active IP Right Grant
- 2007-07-18 BR BRPI0714599-3A patent/BRPI0714599A2/pt not_active IP Right Cessation
- 2007-07-18 CN CN2007800279925A patent/CN101495478B/zh not_active Expired - Fee Related
- 2007-07-18 JP JP2009522134A patent/JP5149897B2/ja not_active Expired - Fee Related
- 2007-07-18 KR KR1020097002137A patent/KR20090129981A/ko not_active Abandoned
- 2007-07-18 PT PT07765222T patent/PT2054412E/pt unknown
- 2007-07-18 AU AU2007280780A patent/AU2007280780B2/en not_active Ceased
- 2007-07-18 AT AT07765222T patent/ATE450537T1/de active
- 2007-07-18 DK DK07765222.0T patent/DK2054412T3/da active
- 2007-07-31 TW TW096127870A patent/TWI400240B/zh not_active IP Right Cessation
- 2007-07-31 AR ARP070103373A patent/AR062158A1/es not_active Application Discontinuation
- 2007-07-31 PE PE2007000991A patent/PE20080687A1/es not_active Application Discontinuation
- 2007-07-31 DO DO2007000120A patent/DOP2007000120A/es unknown
- 2007-08-01 CL CL200702240A patent/CL2007002240A1/es unknown
-
2009
- 2009-01-29 IL IL196789A patent/IL196789A/en not_active IP Right Cessation
- 2009-02-02 US US12/364,124 patent/US7863269B2/en not_active Expired - Fee Related
- 2009-02-16 NO NO20090741A patent/NO20090741L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL196789A (en) | 2012-07-31 |
| JP2009545542A (ja) | 2009-12-24 |
| DE502007002219D1 (de) | 2010-01-14 |
| DE102006036023A1 (de) | 2008-02-07 |
| JP5149897B2 (ja) | 2013-02-20 |
| IL196789A0 (en) | 2009-11-18 |
| US20090192150A1 (en) | 2009-07-30 |
| ATE450537T1 (de) | 2009-12-15 |
| ES2336044T3 (es) | 2010-04-07 |
| BRPI0714599A2 (pt) | 2013-04-09 |
| HK1135694A1 (en) | 2010-06-11 |
| EP2054412A2 (de) | 2009-05-06 |
| DK2054412T3 (da) | 2010-04-19 |
| NO20090741L (no) | 2009-02-16 |
| AR062158A1 (es) | 2008-10-22 |
| DOP2007000120A (es) | 2008-02-29 |
| TWI400240B (zh) | 2013-07-01 |
| CA2663332A1 (en) | 2008-02-07 |
| WO2008014888A2 (de) | 2008-02-07 |
| EP2054412B1 (de) | 2009-12-02 |
| PE20080687A1 (es) | 2008-07-24 |
| PT2054412E (pt) | 2010-02-04 |
| CA2663332C (en) | 2015-06-02 |
| AU2007280780A1 (en) | 2008-02-07 |
| MX2009000408A (es) | 2009-01-27 |
| TW200821308A (en) | 2008-05-16 |
| WO2008014888A3 (de) | 2008-06-12 |
| CN101495478B (zh) | 2013-03-27 |
| CL2007002240A1 (es) | 2008-02-08 |
| MY148611A (en) | 2013-05-15 |
| US7863269B2 (en) | 2011-01-04 |
| CN101495478A (zh) | 2009-07-29 |
| AU2007280780B2 (en) | 2012-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8466169B2 (en) | SF5 derivatives as PAR1 inhibitors, production thereof, and use as medicaments | |
| KR20090050081A (ko) | 응고 인자 ＩＸａ 억제제로서 사용하기 위한 이소세린 유도체 | |
| KR20100114514A (ko) | Ｐａｒ１ 억제제로서의 트리아졸로피리다진, 이의 제조방법 및 약제로서의 용도 | |
| JP5570434B2 (ja) | Ｐａｒ１阻害剤としてのイミダゾピリダジン類、その製造、及び薬剤としての使用 | |
| RU2446160C2 (ru) | Тартратные производные для применения в качестве ингибиторов фактора свертывания крови ixa | |
| JP2006517589A (ja) | セリンプロテアーゼ・インヒビターとして有用なベンゼンアセトアミド化合物 | |
| KR20090129981A (ko) | 항혈전 활성을 갖는 이미노이미다조피리딘 유도체 | |
| JP4861179B2 (ja) | マトリックスメタロプロテイナーゼの阻害剤として使用される二環式イミノ酸誘導体 | |
| HK1135694B (en) | Imino-imidazo-pyridine derivatives having antithrombotic activity | |
| HK1148956B (en) | Imidazopyridazines as par1 inhibitors, production thereof, and use thereof as medicaments | |
| HK1137419B (en) | Tartrate derivatives for use as coagulation factor ixa inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20090202 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20120717 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20140120 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20140729 |
|
| NORF | Unpaid initial registration fee | ||
| PC1904 | Unpaid initial registration fee |